3VJ-96317-01702
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 945 / CA
- Registered
- 2022-07-30
- Relationship
- Child or adolescent in my care
- Guardian
- X4L-19367-46468
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Pfizer-BioNTech
-
2022-07-15
Dose 2 — Pfizer-BioNTech
-
2022-07-30
Registered in v-safe
- 2022-07-30
- 2022-08-05
- 2022-08-12
- 2022-08-19
- 2022-08-28
-
2022-09-09
Dose 3 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — day 42, dose 3, dependentMedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Recent coldMedDRA releases: 2024-11 · check-in free text available
- 2022-12-09
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Pfizer-BioNTech | No |
| 2 | 2022-07-15 | Pfizer-BioNTech | No |
| 3 | 2022-09-09 | Pfizer-BioNTech | No |
Free text
Release 12 — day 42, dose 3, dependent
Symptoms: Recent cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release